|
ACCP |
American College of Chest Physicians |
|
AIS |
Arterial ischemic stroke |
|
APS |
Antiphospholipid syndrome |
|
ASH |
American Society of Hematolohy |
|
AT |
Antithrombin |
|
BSH |
British Society of Haematology |
|
CPG |
Clinical Practice Guideline |
|
CSVT |
Cerebral sinovenous thrombosis |
|
CT |
Computerized tomography |
|
CTPA |
CT pulmonary angiography |
|
CVAD |
Central venous access device |
|
CVC |
Central venous catheter |
|
CVL |
Cantral venous line |
|
DOACs |
Direct oral anticoagulants |
|
DVT |
Deep venous thrombosis |
|
EPG |
Egyptian Pediatric Clinical Practice Guidelines Committee |
|
FVL |
Factor V Leiden |
|
GDG |
Guidelines Development Group |
|
GPS |
Good practice statement |
|
GRADE |
Grading of Recommendations Assessment, Development and Evaluation |
|
IVC |
Inferior vena cava |
|
JAK2 |
Janase Kinase 2 |
|
LMWH |
Low molecular weight heparin |
|
MRI |
Magnetic resonance imaging |
|
MPN |
Myeloproliferative neoplasms |
|
PC |
Protein C |
|
PE |
Pulmonary embolism |
|
PNH |
Paroxysmal nocturnal hemoglobinuria |
|
PS |
Protein S |
|
PTS |
Post-thrombotic syndrome |
|
PVT |
Portal vein thrombosis |
|
QoE |
Quality of evidence |
|
RVT |
Renal vein thrombosis |
|
SoR |
Strength of recommendation |
|
SVC |
Superior vena cava |
|
tPA |
Tissue plasminogen activator |
|
VKA |
Vitamin K antagonists |
|
VTE |
Venous thromboembolism |